Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07339345 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Single-Arm Clinical Trial of GO Regimen for HLH.

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 14, 2026 (before its estimated June 27, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to investigate the efficacy and safety of Golidocitinib(GO) monotherapy in the treatment of hemophagocytic lymphohistiocytosis.
Trial Details
NCT Number NCT07339345
Lead Sponsor Beijing Friendship Hospital
Conditions
(from sponsor)		 Lymphohistiocytosis, Hemophagocytic
Related terms Lymphohistiocytosis, Hemophagocytic
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov